6 completed. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 6 |
Follow Vascular Disease: new trials by email Literature Review of Vascular Disease trials Research Report on Vascular Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT. SUVED, REIMMUGEN, Grain flour placebo - Coronary Artery Disease, Cerebro Vascular Disease | Phase 3 | Completed | Sujata Vaidya | 96 | 2016-01-01 | 2017-09-26 |
| Is Peri-operative Hyperoxemia a Risk Factor for Postoperative Complications? Oxygen, Air - Vascular Disease | Phase 3 | Completed | Örebro University, Sweden | 184 | 2014-11-01 | 2021-03-04 |
| Efficacy Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension (PAH) ambrisentan - Vascular Disease | Phase 3 | Completed | GlaxoSmithKline | 134 | 2012-12-01 | 2017-06-06 |
| ArterX Surgical Sealant, A Randomized Prospective Multicenter Trial ArterX Surgical Sealant, Gelfoam and Thrombin - Vascular Disease | Phase 3 | Completed | Tenaxis Medical, Inc. | 217 | 2008-09-01 | 2013-01-31 |
| SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) XIENCE V® Everolimus Eluting Coronary Stent, TAXUS® EXPRESS2™ Paclitaxel Eluting Coronary Stent - Stents, Coronary Artery Disease | Phase 3 | Completed | Abbott Medical Devices | 1002 | 2005-06-01 | 2011-11-23 |
| SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System Coronary artery drug eluting stent placement, Coronary artery stent placement - Coronary Artery Disease, Everolimus | Phase 3 | Completed | Abbott Medical Devices | 60 | 2003-12-01 | 2010-01-06 |
Vascular Diseases (6) · Coronary Artery Disease (3) · Myocardial Ischemia (3) · Coronary Stenosis (2) · Cardiovascular Diseases (1) · Coronary Restenosis (1) · Ischemia (1) · Peripheral Arterial Disease (1) · Postoperative Cognitive Complications (1) · Postoperative Complications (1) · Venous Thrombosis (1)
Cardiovascular Diseases (5) · Arterial Occlusive Diseases (3) · Arteriosclerosis (3) · Coronary Disease (3) · Heart Diseases (3) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Atherosclerosis (1) · Cognition Disorders (1) · Cognitive Dysfunction (1) · Embolism and Thrombosis (1) · Mental Disorders (1) · Neurocognitive Disorders (1) · Peripheral Vascular Diseases (1) · Thrombosis (1)
Air (1) · Gelatin Sponge, Absorbable (1) · Oxygen (1) · ambrisentan (1)
Abbott Medical Devices (2) · GlaxoSmithKline (1) · Sujata Vaidya (1) · Tenaxis Medical, Inc. (1) · Örebro University, Sweden (1)
United States (2) · China (1) · Denmark (1) · Germany (1) · India (1) · Netherlands (1) · Sweden (1)
Anil Gupta, MD, PhD (1) · David Cull, MD (1) · Dr Shreepad M Bhat, MD (1) · Gregg W Stone, MD (1) · Patrick Serruys, MD (1)
PMID 24746650, PMID 18430909, PMID 19171853, PMID 19530147, PMID 19758878, PMID 19758913, PMID 19758915, PMID 21232715, PMID 21232716, PMID 22017936, PMID 22115661, PMID 22939276, PMID 25940520, PMID 27770771, PMID 32680480, PMID 32799568